205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.78%
Revenue growth at 75-90% of LSCC's 8.81%. Bill Ackman would push for innovation or market expansion to catch up.
10.01%
Gross profit growth similar to LSCC's 9.35%. Walter Schloss would assume both firms track common industry trends.
15.16%
EBIT growth 1.25-1.5x LSCC's 12.92%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
14.13%
Operating income growth similar to LSCC's 12.92%. Walter Schloss would assume both share comparable operational structures.
10.15%
Net income growth at 50-75% of LSCC's 16.08%. Martin Whitman would question fundamental disadvantages in expenses or demand.
10.00%
EPS growth at 50-75% of LSCC's 14.29%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
9.63%
Diluted EPS growth at 50-75% of LSCC's 15.38%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.11%
Slight or no buybacks while LSCC is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.21%
Slight or no buyback while LSCC is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
0.10%
Dividend growth of 0.10% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
14.65%
OCF growth under 50% of LSCC's 40.73%. Michael Burry might suspect questionable revenue recognition or rising costs.
12.52%
FCF growth under 50% of LSCC's 35.90%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
65.88%
10Y revenue/share CAGR above 1.5x LSCC's 29.95%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
52.11%
5Y revenue/share CAGR above 1.5x LSCC's 7.08%. David Dodd would look for consistent product or market expansions fueling outperformance.
20.69%
3Y revenue/share CAGR above 1.5x LSCC's 12.20%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
320.99%
10Y OCF/share CAGR above 1.5x LSCC's 114.93%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
115.68%
Below 50% of LSCC's 265.85%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
22.95%
3Y OCF/share CAGR under 50% of LSCC's 431.08%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
259.89%
Net income/share CAGR above 1.5x LSCC's 45.05% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
156.30%
5Y net income/share CAGR at 50-75% of LSCC's 233.43%. Martin Whitman might see a shortfall in operational efficiency or brand power.
45.48%
Below 50% of LSCC's 198.85%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
28.12%
10Y equity/share CAGR above 1.5x LSCC's 0.74%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
21.70%
5Y equity/share CAGR 1.25-1.5x LSCC's 19.13%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
11.02%
Below 50% of LSCC's 57.70%. Michael Burry suspects a serious short-term disadvantage in building book value.
686.53%
Dividend/share CAGR of 686.53% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
168.06%
Dividend/share CAGR of 168.06% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.54%
3Y dividend/share CAGR of 64.54% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.44%
AR growth well above LSCC's 0.18%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.80%
Inventory is declining while LSCC stands at 10.31%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.91%
Asset growth above 1.5x LSCC's 0.87%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
9.59%
BV/share growth above 1.5x LSCC's 1.47%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.02%
We have some new debt while LSCC reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
1.30%
R&D dropping or stable vs. LSCC's 14.08%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
No Data
No Data available this quarter, please select a different quarter.